Last visit was: 19 Nov 2025, 14:17 It is currently 19 Nov 2025, 14:17
Close
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Close
Request Expert Reply
Confirm Cancel
User avatar
NandishSS
Joined: 06 Jan 2015
Last visit: 28 Jan 2021
Posts: 720
Own Kudos:
1,721
 [28]
Given Kudos: 579
Location: India
Concentration: Operations, Finance
GPA: 3.35
WE:Information Technology (Computer Software)
Posts: 720
Kudos: 1,721
 [28]
3
Kudos
Add Kudos
25
Bookmarks
Bookmark this Post
Most Helpful Reply
User avatar
olito
Joined: 26 Dec 2017
Last visit: 13 Apr 2019
Posts: 27
Own Kudos:
79
 [6]
Given Kudos: 22
Location: France
GMAT 1: 700 Q50 V34
Products:
GMAT 1: 700 Q50 V34
Posts: 27
Kudos: 79
 [6]
6
Kudos
Add Kudos
Bookmarks
Bookmark this Post
General Discussion
avatar
prashant6923
Joined: 21 Jul 2012
Last visit: 04 Feb 2019
Posts: 69
Own Kudos:
Given Kudos: 52
Concentration: Leadership, Strategy
Posts: 69
Kudos: 92
Kudos
Add Kudos
Bookmarks
Bookmark this Post
User avatar
renjana
Joined: 11 Jun 2015
Last visit: 06 Dec 2019
Posts: 70
Own Kudos:
Given Kudos: 86
Location: India
Concentration: Marketing, Leadership
Posts: 70
Kudos: 31
Kudos
Add Kudos
Bookmarks
Bookmark this Post
Understood the question now .


It looks like the new drug causes nausea and if nausea causes people the stop taking drugs then it wont be preferred drug for treatment .
User avatar
GMATNinjaTwo
User avatar
GMAT Club Verbal Expert
Joined: 20 Nov 2016
Last visit: 02 Oct 2025
Posts: 231
Own Kudos:
Given Kudos: 1,071
GMAT 1: 760 Q48 V47
GMAT 2: 770 Q49 V48
GMAT 3: 770 Q50 V47
GMAT 4: 790 Q50 V51
GRE 1: Q170 V169
Expert
Expert reply
GMAT 4: 790 Q50 V51
GRE 1: Q170 V169
Posts: 231
Kudos: 1,095
Kudos
Add Kudos
Bookmarks
Bookmark this Post
NandishSS
A new drug, taken twice daily for one month, is an effective treatment for a certain disease. The drug now most commonly prescribed for the disease occasionally has serious side effects such as seizures; the new drug has side effects much more frequently, but the worst of them is mild nausea. Therefore, the new drug is clearly preferable as a treatment.

Which of the following, if true, most seriously weakens the argument?

A) It is possible that the drug now most commonly prescribed has side effects that have not yet been attributed to it.
B) People who experience nausea are prone to discontinue use of the new drug prematurely.
C) Other drugs for the disease have typically been prescribed only for patients allergic to the most commonly prescribed drug.
D) People who have received effective treatment for disease do not generally contract the disease again.
E) There is a nonprescription medication that when taken with the new drug prevents the onset of nausea.


Similar Question :

A new drug, taken twice daily for one month
NandishSS, is this in fact a question from the GMATPrep software, or is it simply an edited version of this question from EP2?

We want to make sure that questions with the "GMAT Prep EP2" tag are ACTUAL questions from EP2. Questions BASED on official questions should be tagged with the actual source (i.e. "Self-made question", "Other - Please specify", etc.).
User avatar
SonalSinha803
Joined: 14 Feb 2018
Last visit: 18 Feb 2019
Posts: 306
Own Kudos:
Given Kudos: 29
Posts: 306
Kudos: 319
Kudos
Add Kudos
Bookmarks
Bookmark this Post
Yes I agree A and B are close contenders and A is a bit more appropriate answer. I don't think it is an official question.... Seems poorly designed as A and B both cannot be eliminated with a good reason.

Sent from my Lenovo K53a48 using GMAT Club Forum mobile app
User avatar
aggvipul
Joined: 15 Nov 2017
Last visit: 13 Apr 2022
Posts: 229
Own Kudos:
418
 [1]
Given Kudos: 28
Status:Current Student
Concentration: Operations, Marketing
WE:Operations (Retail: E-commerce)
Posts: 229
Kudos: 418
 [1]
1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
NandishSS
A new drug, taken twice daily for one month, is an effective treatment for a certain disease. The drug now most commonly prescribed for the disease occasionally has serious side effects such as seizures; the new drug has side effects much more frequently, but the worst of them is mild nausea. Therefore, the new drug is clearly preferable as a treatment.

Which of the following, if true, most seriously weakens the argument?

A) It is possible that the drug now most commonly prescribed has side effects that have not yet been attributed to it.
B) People who experience nausea are prone to discontinue use of the new drug prematurely.
C) Other drugs for the disease have typically been prescribed only for patients allergic to the most commonly prescribed drug.
D) People who have received effective treatment for disease do not generally contract the disease again.
E) There is a nonprescription medication that when taken with the new drug prevents the onset of nausea.


Premise: New drug has freq. side effect but their intensity is less therefore new drug is preferable
Missing Link: Freq. of side effect(new drug) does not affect more than the side effect(old drug)

A) It is possible that the drug now most commonly prescribed has side effects that have not yet been attributed to it. - 180 option, it is rather strengthing the argument
B) People who experience nausea are prone to discontinue use of the new drug prematurely.- Bingo!if the sheer one time nausea can make the drug usage discontinued, then this drug can not be preferred for prescription
C) Other drugs for the disease have typically been prescribed only for patients allergic to the most commonly prescribed drug. - we are not at all bothered about other drugs, it is a leap of faith
D) People who have received effective treatment for disease do not generally contract the disease again. - what about the new patients? and even if they do not contract it again then on what grounds we can negate the effectiveness of new drug
E) There is a nonprescription medication that when taken with the new drug prevents the onset of nausea.-we are not at all bothered about the new drug. Also, even if the new drug can be taken into account it would rather strengthen the argument
User avatar
NandishSS
Joined: 06 Jan 2015
Last visit: 28 Jan 2021
Posts: 720
Own Kudos:
1,721
 [1]
Given Kudos: 579
Location: India
Concentration: Operations, Finance
GPA: 3.35
WE:Information Technology (Computer Software)
Posts: 720
Kudos: 1,721
 [1]
Kudos
Add Kudos
Bookmarks
Bookmark this Post
GMATNinjaTwo
NandishSS
A new drug, taken twice daily for one month, is an effective treatment for a certain disease. The drug now most commonly prescribed for the disease occasionally has serious side effects such as seizures; the new drug has side effects much more frequently, but the worst of them is mild nausea. Therefore, the new drug is clearly preferable as a treatment.

Which of the following, if true, most seriously weakens the argument?

A) It is possible that the drug now most commonly prescribed has side effects that have not yet been attributed to it.
B) People who experience nausea are prone to discontinue use of the new drug prematurely.
C) Other drugs for the disease have typically been prescribed only for patients allergic to the most commonly prescribed drug.
D) People who have received effective treatment for disease do not generally contract the disease again.
E) There is a nonprescription medication that when taken with the new drug prevents the onset of nausea.


Similar Question :

A new drug, taken twice daily for one month
NandishSS, is this in fact a question from the GMATPrep software, or is it simply an edited version of this question from EP2?

We want to make sure that questions with the "GMAT Prep EP2" tag are ACTUAL questions from EP2. Questions BASED on official questions should be tagged with the actual source (i.e. "Self-made question", "Other - Please specify", etc.).

HI GMATNinjaTwo ,

Please find the attachment of Question. This not the only question which GMAC have twisted and asked for, but have come across few more question, which are in GMATPrep as Strengthen but in EP2 they have asked to weaken.

I hope it is clear now, Please change the Tag to GMATPrep EP2
Attachments

File comment: GMATPrep EP2 Question
GMATPrep EP2.jpg
GMATPrep EP2.jpg [ 112.22 KiB | Viewed 17252 times ]

User avatar
GMATNinjaTwo
User avatar
GMAT Club Verbal Expert
Joined: 20 Nov 2016
Last visit: 02 Oct 2025
Posts: 231
Own Kudos:
Given Kudos: 1,071
GMAT 1: 760 Q48 V47
GMAT 2: 770 Q49 V48
GMAT 3: 770 Q50 V47
GMAT 4: 790 Q50 V51
GRE 1: Q170 V169
Expert
Expert reply
GMAT 4: 790 Q50 V51
GRE 1: Q170 V169
Posts: 231
Kudos: 1,095
Kudos
Add Kudos
Bookmarks
Bookmark this Post
NandishSS
GMATNinjaTwo
NandishSS
A new drug, taken twice daily for one month, is an effective treatment for a certain disease. The drug now most commonly prescribed for the disease occasionally has serious side effects such as seizures; the new drug has side effects much more frequently, but the worst of them is mild nausea. Therefore, the new drug is clearly preferable as a treatment.

Which of the following, if true, most seriously weakens the argument?

A) It is possible that the drug now most commonly prescribed has side effects that have not yet been attributed to it.
B) People who experience nausea are prone to discontinue use of the new drug prematurely.
C) Other drugs for the disease have typically been prescribed only for patients allergic to the most commonly prescribed drug.
D) People who have received effective treatment for disease do not generally contract the disease again.
E) There is a nonprescription medication that when taken with the new drug prevents the onset of nausea.


Similar Question :

A new drug, taken twice daily for one month
NandishSS, is this in fact a question from the GMATPrep software, or is it simply an edited version of this question from EP2?

We want to make sure that questions with the "GMAT Prep EP2" tag are ACTUAL questions from EP2. Questions BASED on official questions should be tagged with the actual source (i.e. "Self-made question", "Other - Please specify", etc.).

HI GMATNinjaTwo ,

Please find the attachment of Question. This not the only question which GMAC have twisted and asked for, but have come across few more question, which are in GMATPrep as Strengthen but in EP2 they have asked to weaken.

I hope it is clear now, Please change the Tag to GMATPrep EP2
Done! Thank you NandishSS for the confirmation!
avatar
jaisonsunny77
Joined: 05 Jan 2019
Last visit: 25 Aug 2021
Posts: 459
Own Kudos:
Given Kudos: 28
Posts: 459
Kudos: 381
Kudos
Add Kudos
Bookmarks
Bookmark this Post
Type: Weaken the conclusion

Conclusion: the new drug is clearly preferable as a treatment.

A) It is possible that the drug now most commonly prescribed has side effects that have not yet been attributed to it.
- the conclusion is concerned with the ''new drug'', not the drug that is currently prescribed.
B) People who experience nausea are prone to discontinue use of the new drug prematurely. - from the passage, we know that the new drug is known to cause nausea. So, if people discontinue the usage of this new drug as soon as they experience nausea, then we can reasonably infer that their preference for this new drug will decline. Hence, (B) weakens the conclusion. Therefore, (B) is the right answer to this question.

C) Other drugs for the disease have typically been prescribed only for patients allergic to the most commonly prescribed drug.
- the conclusion is not at all concerned with ''other drugs''
D) People who have received effective treatment for disease do not generally contract the disease again.
- irrelevant to the conclusion cited.
E) There is a nonprescription medication that when taken with the new drug prevents the onset of nausea.
- the conclusion is not at all concerned with ''nonprescription medication''.
User avatar
souvik19
Joined: 27 Feb 2021
Last visit: 03 Apr 2023
Posts: 83
Own Kudos:
Given Kudos: 41
Location: India
Posts: 83
Kudos: 34
Kudos
Add Kudos
Bookmarks
Bookmark this Post
prashant6923
Why A is not right? Isn't it true that the patients might be having some side effects which are yet not attributed to the drug in question?


Please note that Option A actually strengthens the argument.

The argument, in a nut shell, is that the new drug should be preferred over the "present common drug". It is preferred because although the frequency of side effect of the common drug is less, it is very serious, whereas even though the frequency of the side effect of the new drug is more, it is not so serious.


So Option A says that there could be some other side effect of the common drug that has not yet been discovered. If that is the case, then the frequency of side effect of common drug will increase, including severe side effects. That should in fact promote the use of new drug and hence strengthens the argument.

Posted from my mobile device
User avatar
Outraise_24
Joined: 16 Aug 2023
Last visit: 12 Jan 2025
Posts: 1
Given Kudos: 1
Posts: 1
Kudos: 0
Kudos
Add Kudos
Bookmarks
Bookmark this Post
Because the presence of other side effects does not necessarily lead to discontinuing the use of the drug. Option B, on the other hand, mentioned discontinuing the usage of the drug by people experiencing nausea. So, option B is correct.
prashant6923
Why A is not right? Isn't it true that the patients might be having some side effects which are yet not attributed to the drug in question?
User avatar
Contropositive
Joined: 21 Oct 2023
Last visit: 17 Feb 2025
Posts: 54
Own Kudos:
Given Kudos: 21
Location: India
GMAT Focus 1: 635 Q86 V81 DI77
GMAT Focus 1: 635 Q86 V81 DI77
Posts: 54
Kudos: 16
Kudos
Add Kudos
Bookmarks
Bookmark this Post
KarishmaB GMATNinjaTwo MartyMurray

I am lil confused about the correct answer (B)

Stimulus says:
''new drug'' is effective, side effect much frequent but worst is ''mild nausea''
''Drug now'' has serious side effects such as seizures
Hence, new drug is clearly preferable as a treatment

I have two concerns about (B):
1. How big is the population of people who ''experience nausea''? Maybe they are 5 out of 10 million or maybe 5million out of 10 million?
2. Stimulus conclusion is based on facts, how can we weaken it by saying that a small subset won't prefer it?
Even if people who ''experience nausea'' reject the new drug, we can still say that ''new drug is a preferable treatment, right?
User avatar
MartyMurray
Joined: 11 Aug 2023
Last visit: 19 Nov 2025
Posts: 1,632
Own Kudos:
6,125
 [2]
Given Kudos: 173
GMAT 1: 800 Q51 V51
Expert
Expert reply
GMAT 1: 800 Q51 V51
Posts: 1,632
Kudos: 6,125
 [2]
2
Kudos
Add Kudos
Bookmarks
Bookmark this Post
Contropositive
I am lil confused about the correct answer (B)

Stimulus says:
''new drug'' is effective, side effect much frequent but worst is ''mild nausea''
''Drug now'' has serious side effects such as seizures
Hence, new drug is clearly preferable as a treatment

I have two concerns about (B):
1. How big is the population of people who ''experience nausea''? Maybe they are 5 out of 10 million or maybe 5million out of 10 million?
2. Stimulus conclusion is based on facts, how can we weaken it by saying that a small subset won't prefer it?
Even if people who ''experience nausea'' reject the new drug, we can still say that ''new drug is a preferable treatment, right?
What we need to keep in mind to understand why (B) works is that, to weaken an argument, an answer choice does not have to destroy the argument or prove the conclusion incorrect. It has only to cast doubt on the conclusion.

In the case of this question, as you suggested, the fact that "People who experience nausea are prone to discontinue use of the new drug prematurely," does not prove that the new drug is not preferable.

At the same time what (B) says combined with "the new drug has side effects much more frequently, but the worst of them is mild nausea," from the passage indicates that IT COULD BE that, relatively "frequently," people who use the new drug experience nausea and discontinue using it.

So, (B) indicates that there may be a major drawback to use of the new drug, and thus (B) casts doubt on the conclusion that the new drug is preferable as a treatment.

The new drug could still be preferable, but (B) provides reason to wonder whether it is, and that's all the correct answer to this Weaken question has to do.
User avatar
KarishmaB
Joined: 16 Oct 2010
Last visit: 19 Nov 2025
Posts: 16,267
Own Kudos:
77,000
 [1]
Given Kudos: 482
Location: Pune, India
Expert
Expert reply
Active GMAT Club Expert! Tag them with @ followed by their username for a faster response.
Posts: 16,267
Kudos: 77,000
 [1]
1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
NandishSS
A new drug, taken twice daily for one month, is an effective treatment for a certain disease. The drug now most commonly prescribed for the disease occasionally has serious side effects such as seizures; the new drug has side effects much more frequently, but the worst of them is mild nausea. Therefore, the new drug is clearly preferable as a treatment.

Which of the following, if true, most seriously weakens the argument?

A) It is possible that the drug now most commonly prescribed has side effects that have not yet been attributed to it.
B) People who experience nausea are prone to discontinue use of the new drug prematurely.
C) Other drugs for the disease have typically been prescribed only for patients allergic to the most commonly prescribed drug.
D) People who have received effective treatment for disease do not generally contract the disease again.
E) There is a nonprescription medication that when taken with the new drug prevents the onset of nausea.


Similar Question: A new drug, taken twice daily for one month

For a drug to be an effective treatment, it is important that people take it. Say there is a drug that is very effective at eliminating a disease and has no side effects, but it tastes awful. So much so that after the first dose, people refuse to take it. They are ok with living with the disease instead. Can we say that the drug is even a viable treatment then, forget preferable?
If people refuse to take it, for whatever reasons, it is not a treatment. This is what this question talks about.

Premises:
A new drug is effective at treating a disease.
The current drug occasionally has serious side effects such as seizures;
The new drug has side effects much more frequently, but the worst of them is mild nausea (supposedly a far milder side effect).

Conclusion: The new drug is clearly preferable as a treatment.

How can we weaken it?

A) It is possible that the drug now most commonly prescribed has side effects that have not yet been attributed to it.

It says that it is possible that the current drug has side effects that have not been identified yet. This strengthens our conclusion, if anything - that the new drug is preferable to the current drug.

B) People who experience nausea are prone to discontinue use of the new drug prematurely.

Exactly. It says that the side effect is such that people refuse to take the drug. Then it is not an effective treatment. It weakens our conclusion.

C) Other drugs for the disease have typically been prescribed only for patients allergic to the most commonly prescribed drug.

This tells us that drugs other than the current one have been prescribed only for patients allergic to the current one. This statement has no impact on the efficacy of the new drug.

D) People who have received effective treatment for disease do not generally contract the disease again.

Irrelevant.

E) There is a nonprescription medication that when taken with the new drug prevents the onset of nausea.

This strengthens our argument. The new drug is effective if whatever side effects it has can also be easily preemptively handled by a nonprescription medication (which implies a mild medication).

Answer (B)
User avatar
KarishmaB
Joined: 16 Oct 2010
Last visit: 19 Nov 2025
Posts: 16,267
Own Kudos:
Given Kudos: 482
Location: Pune, India
Expert
Expert reply
Active GMAT Club Expert! Tag them with @ followed by their username for a faster response.
Posts: 16,267
Kudos: 77,000
Kudos
Add Kudos
Bookmarks
Bookmark this Post
Contropositive
KarishmaB GMATNinjaTwo MartyMurray

I am lil confused about the correct answer (B)

Stimulus says:
''new drug'' is effective, side effect much frequent but worst is ''mild nausea''
''Drug now'' has serious side effects such as seizures
Hence, new drug is clearly preferable as a treatment

I have two concerns about (B):
1. How big is the population of people who ''experience nausea''? Maybe they are 5 out of 10 million or maybe 5million out of 10 million?
2. Stimulus conclusion is based on facts, how can we weaken it by saying that a small subset won't prefer it?
Even if people who ''experience nausea'' reject the new drug, we can still say that ''new drug is a preferable treatment, right?

1. Since the side effects occur much more frequently with the new drug, we are given the impression that a big chunk of people experience nausea.
2. A drug is a treatment if it is accepted by the masses and then works effectively. It could have the potential of being a great treatment but still may not be viable (as discussed above in my solution)
Moderators:
GMAT Club Verbal Expert
7443 posts
GMAT Club Verbal Expert
231 posts
189 posts